Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine

BACKGROUND: The U.S. Centers for Disease Control and Prevention (CDC) recommended a new regimen for treatment of latent tuberculosis (three months of weekly isoniazid and rifapentine) in late 2011. While completion rates of this regimen were reported to be higher than nine months of isoniazid, littl...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Infect Dis
Main Authors: McClintock, Adelaide H., Eastment, McKenna, McKinney, Christy M., Pitney, Caroline L., Narita, Masahiro, Park, David R., Dhanireddy, Shireesha, Molnar, Alexandra
格式: Artigo
語言:Inglês
出版: BioMed Central 2017
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310079/
https://ncbi.nlm.nih.gov/pubmed/28196479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2245-8
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍